Prediction of Biochemical Recurrence after Radical Prostatectomy Using Peritumoral Lymphatic Vessel Density in Biopsy Specimens in Patients with Localized Prostate Cancer

被引:3
作者
Kuroda, Kenji [1 ]
Horiguchi, Akio [1 ]
Asano, Takako [1 ]
Tasaki, Shinsuke [1 ]
Yoshii, Hidehiko [1 ]
Sato, Akinori [1 ]
Asakuma, Junichi [1 ]
Ito, Keiichi [1 ]
Seguchi, Kenji [1 ]
Sumitomo, Makoto [1 ]
Asano, Tomohiko [1 ]
机构
[1] Natl Def Med Coll, Dept Urol, Tokorozawa, Saitama 3598513, Japan
关键词
Peritumoral lymphatic vessel density; Positive biopsy core; Biochemical recurrence; Prostate cancer; GERM-CELL TUMORS; LYMPHOVASCULAR INVASION; PROGNOSTIC-SIGNIFICANCE; RADIATION-THERAPY; ANTIGEN; PSA; FAILURE; DISEASE; RISK;
D O I
10.1159/000335275
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Lymphatic invasion has been associated with biochemical recurrence (BCR), and many patients with postoperative elevation of prostate-specific antigen (PSA) develop distant metastases within several years. We previously found peritumoral lymphatic vessel density (PTLD) in biopsy cores to be an independent predictor of lymphatic invasion in radical prostatectomy specimens, so we speculate that PTLD parameters in biopsy specimens could also be independent predictors of BCR after surgery. Patients and Methods: We obtained positive biopsy cores from 110 patients who underwent radical prostatectomy at our institution. Biopsy cores were immunostained with the D2-40 monoclonal antibody, which specifically and selectively detects lymphatic endothelium. We evaluated differences between the BCR-free survival rates and used univariate and multivariate analyses to detect independent predictors of BCR. Results: The results of a Cox proportional hazards model showed that lymphatic invasion in prostatectomy specimens was one of the independent postoperative prognostic factors for BCR (p = 0.0338). An additional model showed that one PTLD parameter, maximal PTLD, was among the independent preoperative predictors of lower BCR-free survival rates (p = 0.0200). Conclusions: Information about PTLD in prostate biopsy specimens could be helpful for selecting patients as radical prostatectomy candidates, and patients with high PTLD values should be carefully monitored after surgery. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:18 / 24
页数:7
相关论文
共 26 条
[1]   INCIDENCE AND PROGNOSTIC-SIGNIFICANCE OF LYMPHATIC AND VASCULAR INVASION IN RADICAL PROSTATECTOMY SPECIMENS [J].
BAHNSON, RR ;
DRESNER, SM ;
GOODING, W ;
BECICH, MJ .
PROSTATE, 1989, 15 (02) :149-155
[2]   Prognostic significance of lymphovascular invasion in clinically localized prostate cancer after radical prostatectomy [J].
Baydar, Dilek Ertoy ;
Baseskioglu, Barbaros ;
Ozen, Haluk ;
Geyik, Pinar Ozdemir .
THESCIENTIFICWORLDJOURNAL, 2008, 8 :303-312
[3]   Lymphovascular invasion in prostate cancer - Prognostic significance in patients treated with radiotherapy after radical prostatectomy [J].
Brooks, JP ;
Albert, PS ;
O'Connell, J ;
McLeod, DG ;
Poggi, MM .
CANCER, 2006, 106 (07) :1521-1526
[4]   Biochemical Recurrence After Radical Prostatectomy: Multiplicative Interaction Between Surgical Margin Status and Pathological Stage [J].
Budaeus, Lars ;
Isbarn, Hendrik ;
Eichelberg, Christian ;
Lughezzani, Giovanni ;
Sun, Maxine ;
Perrotte, Paul ;
Chun, Felix K. H. ;
Salomon, Georg ;
Steuber, Thomas ;
Koellermann, Jens ;
Sauter, Guido ;
Ahyai, Sascha A. ;
Zacharias, Mario ;
Fisch, Margit ;
Schlomm, Thorsten ;
Haese, Alexander ;
Heinzer, Hans ;
Huland, Hartwig ;
Montorsi, Francesco ;
Graefen, Markus ;
Karakiewicz, Pierre I. .
JOURNAL OF UROLOGY, 2010, 184 (04) :1341-1346
[5]   Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy [J].
D'Amico, AV ;
Renshaw, AA ;
Sussman, B ;
Chen, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (04) :440-447
[6]   Predicting prostate-specific antigen recurrence established: Now, who will survive? [J].
D'Amico, AV .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (15) :3188-3190
[7]   Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy [J].
D'Amico, AV ;
Moul, JW ;
Carroll, PR ;
Sun, L ;
Lubeck, D ;
Chen, MH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (18) :1376-1383
[8]   Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins [J].
Freedland, SJ ;
Terris, MK ;
Presti, JC ;
Amling, CL ;
Kane, CJ ;
Trock, B ;
Aronson, WJ .
JOURNAL OF UROLOGY, 2004, 172 (02) :520-524
[9]   Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy [J].
Freedland, SJ ;
Sutter, ME ;
Dorey, F ;
Aronson, WJ .
UROLOGY, 2003, 61 (02) :365-369
[10]   Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer [J].
Han, M ;
Partin, AW ;
Zahurak, M ;
Piantadosi, S ;
Epstein, JI ;
Walsh, PC .
JOURNAL OF UROLOGY, 2003, 169 (02) :517-523